Posted on Apr. 22nd, 2013 at 4:00pm
Mead Johnson is excited to announce that a new independent study published online this week in the Journal of Pediatrics shows significantly more infants with cow’s milk allergy who receive Nutramigen® LGG®, an extensively hydrolyzed formula that includes Lactobacillus rhamnosus GG (LGG), built a tolerance to cow’s milk compared to those fed other infant formulas used in the study.
Specifically, nearly four out of five (78.9 percent) infants fed Nutramigen LGG built a tolerance to cow’s milk at 12 months, compared with infants fed other products* such as extensively hydrolyzed casein formula (43.6 percent), rice hydrolyzed formula ( 32.6 percent), soy based formulas (23.6 percent) or amino-acid based formulas (18.2 percent).
Historically, children with cow’s milk allergy didn’t build tolerance until three to five years of age. Since Nutramigen LGG helps significantly more babies build tolerance to cow’s milk at 12 months, relatively more infants may be able to resume a normal diet sooner, resulting in a better diversified diet, leading to an improved quality of life.
This is the first study to compare the impact of Nutramigen LGG to different formulas based on duration of cow’s milk allergy in children. This study further builds upon the 70-year history of Nutramigen, which has more breadth and depth of clinical trials than any other formula designed for cow’s milk allergy.
The study is also being presented May 9 at the 46th Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN).